EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients

Manuj Mayank Shah, Sarah Hussain, Binuri Hapuarachchy, Reed Towle Jenkins, David J. Farhat, Heather McDade, Al-Faraaz Kassam, Elizabeth A. King, Russell Wesson, Sharon Weeks, Andrew M. Cameron, Allan B. Massie und 3 weitere

Livers · 13.05.2026 · 6 (3) · 42

DOI: 10.3390/livers6030042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Livers, online erschienen am 13.05.2026. Verfasst von Manuj Mayank Shah und 14 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Simultaneous liver–kidney transplantation (SLK) eligible candidates may receive SLK or liver-alone transplant (LA) with access to kidney transplant after initial LA (KAL). We aimed to characterize SLK-eligible recipient outcomes according to treatment approach.

Methods

This study utilized 2017–2023 SRTR data to identify SLK-eligible deceased donor liver transplants. Recipients were placed into two groups based on whether SLK was performed; non-SLK patients were sub-stratified into LA and KAL cohorts. After baseline comparisons, 2-year patient and graft survival outcomes were characterized by univariable and multivariable Cox proportional hazard regression and Kaplan–Meier analysis.

Results

Among 4879 candidates identified, 3746 (76.8%) underwent SLK, 1023 (21.0%) LA, and 110 (2.3%) KAL. SLK recipients maintained the highest eGFRs at 6 months, 1 year, and 2 years post-transplant (p < 0.01). Compared to SLK recipients, non-SLK recipients had a higher 2-year risk of mortality (aHR 2.46, p < 0.01), all-cause events (aHR 1.91, p < 0.01), and liver graft failure (HR 1.55, p = 0.02). LA conferred a higher 2-year mortality risk (aHR 2.98, p < 0.01) and all-cause event risk (aHR 2.25, p < 0.01), while KAL had comparable mortality risk to SLK (aHR 0.43, p = 0.40).

Conclusions

When SLK-eligible candidates undergo transplants, SLK remains the optimal path forward, even when a safety net kidney can be performed.

Zitieren

APA

Shah, M. M., Hussain, S., Hapuarachchy, B., Jenkins, R. T., Farhat, D. J., McDade, H., Kassam, A., King, E. A., Wesson, R., Weeks, S., Cameron, A. M., Massie, A. B., Segev, D. L., Gurakar, A., & Philosophe, B. (2026). Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients. Livers, 6(3), 42. https://doi.org/10.3390/livers6030042

Vancouver

Shah MM, Hussain S, Hapuarachchy B, Jenkins RT, Farhat DJ, McDade H, et al. Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients. Livers. 2026;6(3):42. doi:10.3390/livers6030042

BibTeX
@article{Shah2026,
  author = {Shah, Manuj Mayank and Hussain, Sarah and Hapuarachchy, Binuri and Jenkins, Reed Towle and Farhat, David J. and McDade, Heather and Kassam, Al-Faraaz and King, Elizabeth A. and Wesson, Russell and Weeks, Sharon and Cameron, Andrew M. and Massie, Allan B. and Segev, Dorry L. and Gurakar, Ahmet and Philosophe, Benjamin},
  title = {Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients},
  journal = {Livers},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {42},
  doi = {10.3390/livers6030042}
}
Kostenlos starten →